The Fixed Dose Combination of Sofosbuvir and Velpatasvir is Safe and Effective in Patients of Chronic Hepatitis C With End-stage Renal Disease
Article in Journal of Clinical and Experimental Hepatology (February 2024)
The most recent citing publications are shown below. View all 68 publications that cite this research output on Dimensions.
Efficacy of Daclatasvir and Half Dose Sofosbuvir in the Treatment of Hepatitis –C Virus Infection in Patients of Maintanance Hemodialysis-3 Years Trial in A Tertiary Renal Center
Article in Journal of Bangladesh College of Physicians and Surgeons (March 2023)
Protein Abundance of Drug Metabolizing Enzymes in Human Hepatitis C Livers
Article in International Journal of Molecular Sciences (February 2023)